Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647-Reference-Cited by-同舟云学术

Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647

Published:2007-06-15 Issue:12 Volume:13 Page:3713-3723
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Gendreau Steven B.,Ventura Richard,Keast Paul,Laird A. Douglas,Yakes F. Michael,Zhang Wentao,Bentzien Frauke,Cancilla Belinda,Lutman Jeffery,Chu Felix,Jackman Lisa,Shi Yongchang,Yu Peiwen,Wang Jing,Aftab Dana T.,Jaeger Christopher T.,Meyer Stephanie M.,De Costa Anushka,Engell Kelly,Chen Jason,Martini Jean-Francois,Joly Alison H.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of resistance to anti-HER2 antibodies in breast cancer;Overcoming Cancers Resistant to HER-2 Antibodies;2024

2. Optimization of the 4-anilinoquin(az)oline scaffold as epidermal growth factor receptor (EGFR) inhibitors for chordoma utilizing a toxicology profiling assay platform;Scientific Reports;2022-07-27

3. Polypharmacology in Clinical Applications—Anticancer Polypharmacology;Polypharmacology;2022

4. In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling;Molecular Cancer Therapeutics;2021-03-30

5. Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway;Pharmaceutical Biology;2021-01-01